APP
MDXG icon

Alpha Paradigm Partners’s MiMedx Group MDXG Stock Holding History

Alpha Paradigm Partners’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-53,407
Closed -$550K – 616
2021
Q1 		$550K Buy
+53,407
New +$516K 0.21% 146

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Alpha Paradigm Partners's MDXG Position: Q2 2021 in Review

Alpha Paradigm Partners sold out of MiMedx Group (MDXG) in Q2 2021, closing a stake of 53,407 shares — an estimated $550K sold.

Alpha Paradigm Partners first reported a position in MDXG in Q1 2021 and held it in 1 quarter. The position peaked at $550K in Q1 2021. 138 funds tracked by Wall St. Rank hold MDXG as of Q2 2021.

  • Alpha Paradigm Partners reported no remaining MiMedx Group position as of Q2 2021 after selling out during the quarter.
  • Alpha Paradigm Partners sold 53,407 MiMedx Group shares in Q2 2021, an estimated $550K.
  • Alpha Paradigm Partners first reported a position in MiMedx Group in Q1 2021 and held it in 1 quarter.
  • Alpha Paradigm Partners's MiMedx Group position peaked at $550K in Q1 2021.
  • 138 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2021.

Based on Alpha Paradigm Partners's 13F filing for Q2 2021, filed 13 Aug 2021.